The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Somnath Chatterjee
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Somnath Chatterjee, Promoter, Chairman and Joint Managing Director of Suraksha Diagnostic Ltd, bought 7,450 equity shares through an open market purchase on 23 June 2025. His holding rose marginally from 26,14,893 shares (5.020%) to 26,22,343 shares (5.034%) of the company. The acquisition is being disclosed under Regulation 29(2) of SEBI's Takeover Regulations, with the total paid-up equity capital remaining unchanged at 5,20,80,758 shares of ₹2 each. The filing was submitted to both BSE and NSE on 24 June 2025.
This is a small, incremental purchase by a promoter that signals continued confidence in the company, though the change in stake is negligible (just 0.014%). Unlikely to have any meaningful impact on the share price or control dynamics.